MetLife (MET)
(Delayed Data from NYSE)
$71.90 USD
-0.82 (-1.13%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $71.89 -0.01 (-0.01%) 5:26 PM ET
3-Hold of 5 3
A Value D Growth D Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$71.90 USD
-0.82 (-1.13%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $71.89 -0.01 (-0.01%) 5:26 PM ET
3-Hold of 5 3
A Value D Growth D Momentum C VGM
Zacks News
Will Reduced Premiums Hurt MetLife's (MET) Q2 Earnings?
by Zacks Equity Research
MetLife's (MET) second-quarter results are likely to reflect lower profits in the Retirement & Income Solutions and MetLife Holdings businesses.
Everest Group (EG) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Everest Group (EG) delivered earnings and revenue surprises of 37.03% and 0.88%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: MetLife (MET) Q2 Earnings Expected to Decline
by Zacks Equity Research
MetLife (MET) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Lemonade (LMND) Soars 15.6%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Lemonade (LMND) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Zacks Industry Outlook Highlights MetLife, American International Group, Prudential, Assurant and Corebridge Financial
by Zacks Equity Research
MetLife, American International Group, Prudential, Assurant and Corebridge Financial have been highlighted in this Industry Outlook article.
5 Stocks to Watch From the Soft Multiline Insurance Industry
by Tanuka De
Better pricing, product redesigns, technological advancement, high inflation and rate rise are expected to aid multiline insurers like MET, AIG, PRU, AIZ and CRBG.
Why MetLife (MET) is a Top Dividend Stock for Your Portfolio
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does MetLife (MET) have what it takes? Let's find out.
MET or AIG: Which Multiline Insurance Stock is Better-Positioned?
by Zacks Equity Research
MetLife (MET) and American International (AIG) are well-positioned to expand in the multiline insurance space. Let's find out which one fares better via comparative evaluation.
MetLife (MET) is a Top Dividend Stock Right Now: Should You Buy?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does MetLife (MET) have what it takes? Let's find out.
MetLife (MET) Expands Partnership With DentalInsurance.com
by Zacks Equity Research
MetLife (MET) collaborates with DentalInsurance.com to provide impeccable service to customers purchasing dental health insurance.
MetLife (MET) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
MetLife (MET) closed the most recent trading day at $54.98, moving +1.7% from the previous trading session.
MetLife (MET) Gains As Market Dips: What You Should Know
by Zacks Equity Research
MetLife (MET) closed the most recent trading day at $55.50, moving +0.62% from the previous trading session.
MetLife (MET) and Lyra Unite to Improve Employee Mental Health
by Zacks Equity Research
MetLife (MET) partners with Lyra to provide employees with mental health solutions and improve their well-being in difficult situations.
MetLife (MET) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does MetLife (MET) have what it takes? Let's find out.
Zacks Investment Ideas feature highlights: Assurant, Radian Group, Old Republic International , MetLife and Prudential Financial
by Zacks Equity Research
Assurant, Radian Group, Old Republic International , MetLife and Prudential Financial are part of the Zacks Investment Ideas article.
5 Dividend-Paying Multiline Insurers That Ensure Stable Income
by Tanuka De
Multiline insurers like Assurant Inc. (AIZ), Radian Group Inc. (RDN), Old Republic International Corporation (ORI), MetLife Inc. (MET) and Prudential Financial Inc. (PRU), which have an impressive dividend history, offer a breather amid volatility.
MetLife (MET) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, MetLife (MET) closed at $53.76, marking a -1.99% move from the previous day.
MetLife (MET) Launches Pet Health and Wellness App With Microsoft
by Zacks Equity Research
MetLife (MET) launches an enhanced pet insurance app with Microsoft to help pet parents.
3 Top Dividend Stocks to Maximize Your Retirement Income
by Zacks Equity Research
The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.
Why Is MetLife (MET) Down 6.9% Since Last Earnings Report?
by Zacks Equity Research
MetLife (MET) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks
by Zacks Equity Research
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?
Are You Looking for a High-Growth Dividend Stock?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does MetLife (MET) have what it takes? Let's find out.
MetLife (MET) Unveils Reinsurance Deal With Global Atlantic
by Zacks Equity Research
MetLife (MET) inscribes a deal to transfer risks related to its U.S. retail life insurance and fixed annuity products to Global Atlantic. It also announces a $1 billion buyback capacity increase.
3 Top Dividend Stocks to Maximize Your Retirement Income
by Zacks Equity Research
The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.
A Look at Insurance ETFs Post a Mixed Bag Q1
by Sweta Killa
With the Fed slowing down the pace of rate hike and expectations of a pause in further hikes coupled with mixed results of the leading players in the industry, insurance ETFs struggled to find a footing over the last month.